EP Wealth Advisors LLC Buys Shares of 74,542 CVS Health Corporation $CVS

EP Wealth Advisors LLC purchased a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 74,542 shares of the pharmacy operator’s stock, valued at approximately $7,711,000.

A number of other large investors also recently modified their holdings of CVS. BlackRock Inc. bought a new stake in CVS Health during the 2nd quarter worth $12,747,462,000. Vanguard Group Inc. increased its holdings in CVS Health by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 120,709,530 shares of the pharmacy operator’s stock worth $9,579,508,000 after purchasing an additional 1,824,424 shares in the last quarter. State Street Corp raised its position in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Capital International Investors boosted its stake in shares of CVS Health by 3.4% during the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after purchasing an additional 900,153 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of CVS Health during the fourth quarter worth about $1,666,265,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

CVS Health stock opened at $93.01 on Friday. The stock’s 50 day moving average is $102.02 and its 200 day moving average is $88.86. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The firm has a market cap of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health’s payout ratio is presently 70.37%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CVS. Cantor Fitzgerald upped their price objective on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Argus upped their price target on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday. Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Finally, Truist Financial boosted their price objective on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.